MedMira Inc. (MMIRF)
OTCMKTS · Delayed Price · Currency is USD
0.0133
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST
MedMira Revenue
MedMira had revenue of 54.21K CAD in the quarter ending October 31, 2025, a decrease of -12.18%. This brings the company's revenue in the last twelve months to 232.99K, down -9.49% year-over-year. In the fiscal year ending July 31, 2025, MedMira had annual revenue of 240.51K, down -41.70%.
Revenue (ttm)
232.99K CAD
Revenue Growth
-9.49%
P/S Ratio
216.92
Revenue / Employee
4.48K CAD
Employees
52
Market Cap
36.06M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 240.51K | -172.06K | -41.70% |
| Jul 31, 2024 | 412.57K | -19.96K | -4.61% |
| Jul 31, 2023 | 432.53K | -519.60K | -54.57% |
| Jul 31, 2022 | 952.13K | -1.19M | -55.60% |
| Jul 31, 2021 | 2.14M | 1.23M | 133.33% |
| Jul 31, 2020 | 919.07K | 391.63K | 74.25% |
| Jul 31, 2019 | 527.45K | -61.43K | -10.43% |
| Jul 31, 2018 | 588.87K | -158.47K | -21.20% |
| Jul 31, 2017 | 747.34K | -1.51M | -66.89% |
| Jul 31, 2016 | 2.26M | -1.80M | -44.31% |
| Jul 31, 2015 | 4.05M | 1.52M | 60.29% |
| Jul 31, 2014 | 2.53M | 526.72K | 26.32% |
| Jul 31, 2013 | 2.00M | 1.03M | 106.20% |
| Jul 31, 2012 | 970.63K | - | - |
| Jul 31, 2011 | - | - | - |
| Jul 31, 2010 | - | - | - |
| Jul 31, 2009 | - | - | - |
| Jul 31, 2008 | - | - | - |
| Jul 31, 2007 | - | - | - |
| Jul 31, 2006 | - | - | - |
| Jul 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Apparatus Regenerative Technology | 743.00K |
| Zenith Capital | 500.00K |
| Provectus Biopharmaceuticals | 350.44K |
| ZIVO Bioscience | 209.03K |
| Arch Biopartners | 198.11K |
MedMira News
- 6 weeks ago - MedMira (MMIRF) Reports Q1 Revenue Decline and Reduced Net Loss - GuruFocus
- 6 weeks ago - Medmira reports Q1 results - Seeking Alpha
- 6 weeks ago - MedMira Reports First Quarter Results FY2026 - Accesswire
- 2 months ago - MedMira Reports FY2025 Fourth Quarter and Year End Financial Results - Accesswire
- 6 months ago - Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis - Accesswire
- 7 months ago - MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada - Accesswire
- 8 months ago - MedMira Reports Second Quarter Results FY2025 - Accesswire
- 10 months ago - MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense - Accesswire